AstraZeneca (AZN)

Add to Watchlists
Create an Alert
62.52 +0.07  +0.11% NYSE Apr 15, 8:00PM BATS Real time Currency in USD

AstraZeneca Cash from Operations (TTM):

7.40B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Operations (TTM) Chart

Pro Export Data
Pro Save Image

AstraZeneca Historical Cash from Operations (TTM) Data

Pro Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 7.40B
Sept. 30, 2013 7.77B
June 30, 2013 7.961B
March 31, 2013 7.606B
Dec. 31, 2012 6.948B
Sept. 30, 2012 7.169B
June 30, 2012 7.783B
March 31, 2012 7.471B
Dec. 31, 2011 7.821B
Sept. 30, 2011 8.312B
June 30, 2011 8.742B
March 31, 2011 10.83B
Dec. 31, 2010 10.68B
Sept. 30, 2010 11.20B
June 30, 2010 11.17B
March 31, 2010 11.25B
Dec. 31, 2009 11.74B
Sept. 30, 2009 10.45B
June 30, 2009 9.784B
March 31, 2009 Go Pro
Dec. 31, 2008 Go Pro
Sept. 30, 2008 Go Pro
June 30, 2008 Go Pro
March 31, 2008 Go Pro
Dec. 31, 2007 Go Pro
   
Sept. 30, 2007 Go Pro
June 30, 2007 Go Pro
March 31, 2007 Go Pro
Dec. 31, 2006 Go Pro
Sept. 30, 2006 Go Pro
June 30, 2006 Go Pro
March 31, 2006 Go Pro
Dec. 31, 2005 Go Pro
Sept. 30, 2005 Go Pro
June 30, 2005 Go Pro
March 31, 2005 Go Pro
Dec. 31, 2004 Go Pro
Sept. 30, 2004 Go Pro
June 30, 2004 Go Pro
March 31, 2004 Go Pro
Dec. 31, 2003 Go Pro
Sept. 30, 2003 Go Pro
June 30, 2003 Go Pro
March 31, 2003 Go Pro
Dec. 31, 2002 Go Pro
Sept. 30, 2002 Go Pro
June 30, 2002 Go Pro
March 31, 2002 Go Pro
Dec. 31, 2001 Go Pro
Sept. 30, 2001 Go Pro

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Operations

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More

Get data for
Advertisement

AZN Cash from Operations (TTM) Benchmarks

Companies
GlaxoSmithKline 11.90B
Pfizer 17.76B
Novartis 13.17B

AZN Cash from Operations (TTM) Range, Past 5 Years

Minimum 6.948B Dec 2012
Maximum 11.74B Dec 2009
Average 9.057B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.